Natera Stock

Natera EBIT

The EBIT of Natera (NTRA) as of Aug 9, 2026 is -309.91 M USD. In the previous year, EBIT was -222.29 M USD — a change of 39.41% (lower).

EBIT

-309.91 MUSD

YoY

39.41%

Last updated:

In 2026, Natera's EBIT was -309.91 M USD, a 39.41% increase from the -222.29 M USD EBIT recorded in the previous year.

The Natera EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (k USD)
Date
EBIT (k USD)
Jan 1, 2023
-446,245.00 base
Jan 1, 2024
-222,294.00 base
Jan 1, 2025
-309,911.00 base
Jan 1, 2026 (e)
-1.12 M base
Jan 1, 2027 (e)
-1.33 M base
Jan 1, 2028 (e)
-1.61 M base
Jan 1, 2029 (e)
-1.90 M base
Jan 1, 2030 (e)
-2.24 M base
YEAREBIT (k USD)
2030 est -2.24 M
2029 est -1.90 M
2028 est -1.61 M
2027 est -1.33 M
2026 est -1.12 M
2025 -309,911.00
2024 -222,294.00
2023 -446,245.00
2022 -541,040.00
2021 -462,793.00
2020 -222,125.00
2019 -116,287.00
2018 -117,357.00
2017 -134,027.00
2016 -96,488.00
2015 -59,838.00
2014 665.00
2013 -25,268.00
2012 -19,215.00
Access this data via the Eulerpool API

Natera Revenue

Natera Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.08 B USD
-446.25 M USD
-434.80 M USD
Jan 1, 2024
1.70 B USD
-222.29 M USD
-190.43 M USD
Jan 1, 2025
2.31 B USD
-309.91 M USD
-208.16 M USD
Jan 1, 2026 (e)
2.80 B USD
-1.12 B USD
-225.07 M USD
Jan 1, 2027 (e)
3.33 B USD
-1.33 B USD
-41.48 M USD
Jan 1, 2028 (e)
4.01 B USD
-1.61 B USD
211.73 M USD
Jan 1, 2029 (e)
4.73 B USD
-1.90 B USD
337.72 M USD
Jan 1, 2030 (e)
5.59 B USD
-2.24 B USD
732.92 M USD

Natera Margins

Natera stock margins

The Natera margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Natera. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Natera.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
45.52 %
-41.22 %
-40.16 %
Jan 1, 2024
60.30 %
-13.10 %
-11.22 %
Jan 1, 2025
64.85 %
-13.44 %
-9.03 %
Jan 1, 2026 (e)
64.85 %
-40.10 %
-8.05 %
Jan 1, 2027 (e)
64.85 %
-40.10 %
-1.25 %
Jan 1, 2028 (e)
64.85 %
-40.10 %
5.27 %
Jan 1, 2029 (e)
64.85 %
-40.10 %
7.14 %
Jan 1, 2030 (e)
64.85 %
-40.10 %
13.11 %

Natera Stock analysis

What does Natera do? Natera Inc. is an American company headquartered in San Carlos, California. It was founded in 2004 by Matthew Rabinowitz and has been listed on the NASDAQ under the ticker symbol "NTRA" since 2015. The company is a leading provider of diagnostic tests and analyses and specializes in genetic analysis and diagnostic technologies. Natera specializes in tests for various medical areas, particularly in oncology diagnostics. The company's vision is to improve the quality of life for millions of people worldwide by offering innovative diagnostic tests to detect diseases early and ensure optimal treatment. Natera offers a wide range of products tailored to the needs of consumers, physicians, and scientists. The company operates in three business areas: 1) Women's Health: Natera offers tests for women and couples to determine the risk of hereditary diseases. For example, the company offers a test that allows analysis of fetal DNA from the mother's blood, allowing detection of genetic abnormalities in the fetus before birth. Additionally, Natera offers the Panorama test, which provides tests for genetic anomalies in unborn babies that can be used to determine the risk for chromosomal abnormalities and genetic mutations. 2) Oncology: In the field of oncology, Natera offers a wide range of diagnostic tests targeting developments and trends in cancer research. The tests aim to enable accurate diagnosis and prognosis, as well as provide individualized treatment for each patient. The company offers tests that assess the current tumor growth and metastatic potential, enable determination of tumor burden in cells, and provide tests for specific mutations required for determining optimal treatment. 3) Genomic Analysis: In the field of genomic analysis, Natera offers a broad range of tests available to researchers and scientists. This includes genetic variants and biological mechanisms that cause diseases. The company is also committed to developing its tests through artificial intelligence (AI) and machine learning. The goal is to provide more accurate and faster results, improve clinical decisions, and advance research and development of new diagnostics. Conclusion: Natera is a leading company in the field of diagnostic tests and analyses in the field of genomic analysis. The company has a long history of research and development of innovative product solutions for the medical community. One important focus of the company is to improve women's health and be able to detect risks for genetic diseases early; the other focus is on oncology diagnostic tools to determine optimal treatment for cancer patients. The company is constantly striving to further develop its tests and integrate new research findings and technologies to support the medical science community. Natera is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Natera's EBIT

Natera's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Natera's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Natera's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Natera’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Natera stock

EBIT of Natera is -309.91 M USD in 2026.

EBIT of Natera changed from -222.29 M USD to -309.91 M USD, representing a 39.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Natera since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Natera historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Natera

All Key Metrics — Natera